Is Bubs Australia Ltd the next a2 Milk Company Ltd (Australia)?

There's a new infant formula company on the ASX by the name of Bubs Australia Ltd (ASX:BUB). Could it be the next a2 Milk Company Ltd (Australia) (ASX:A2M)?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Considering the recent plight of Bellamy's Australia Ltd (ASX: BAL), investors could be forgiven for giving any up-and-coming infant formula companies a wide berth.

But that certainly wasn't the case yesterday when the shares of Bubs Australia Ltd (ASX: BUB) listed on the ASX through a reverse takeover of Hillcrest Litigation Services.

With a listing price of 10 cents, investors scrambled to get hold of shares causing them to rocket higher by 35% on day one to finish the day at 13.5 cents.

Bubs is an award-winning specialist manufacturer of goats milk infant formula and organic baby food that is stocked by Wesfarmers Ltd (ASX: WES) through its Coles supermarkets.

Like a2 Milk Company Ltd (Australia) (ASX: A2M), Bubs also has a growing presence in the China market through online retail giant JD.com.

Interestingly on its board of directors is Nancy Zhang, the wife of billionaire JD.com founder Richard Liu. I believe her involvement and in particular her knowledge of the Chinese retail market will be a valuable asset moving forward.

In FY 2016 the company delivered sales of $4.3 million, up from $2 million a year earlier. If it can find its footing in a crowded Chinese market then I believe there is a good chance of this strong growth continuing for some time to come.

But is Bubs a buy?

So far I like what I have seen with Bubs. I believe it has a quality product, a strong brand, a growing retail presence, and an influential and experienced board of directors.

But it is of course still early days and therefore comes with reasonably higher than normal investment risk.

For this reason I would suggest you restrict any investment in the company to just a small part of your portfolio at this point in time.

Motley Fool contributor James Mickleboro has no position in any stocks mentioned. The Motley Fool Australia owns shares of A2 Milk and Bellamy's Australia. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »